US BANCORP \DE\ - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 70 filers reported holding ANTARES PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$8,000
-33.3%
1,990
-38.6%
0.00%
Q4 2021$12,000
+71.4%
3,240
+62.8%
0.00%
Q3 2021$7,000
-22.2%
1,9900.0%0.00%
Q2 2021$9,000
+12.5%
1,9900.0%0.00%
Q1 2021$8,0000.0%1,9900.0%0.00%
Q4 2020$8,000
+60.0%
1,9900.0%0.00%
Q3 2020$5,0000.0%1,9900.0%0.00%
Q2 2020$5,000
-16.7%
1,990
-20.3%
0.00%
Q1 2020$6,000
-45.5%
2,4980.0%0.00%
Q4 2019$11,000
+37.5%
2,4980.0%0.00%
Q3 2019$8,000
-11.1%
2,4980.0%0.00%
Q2 2019$9,000
-71.0%
2,498
-75.9%
0.00%
Q1 2019$31,000
+14.8%
10,382
+3.8%
0.00%
Q4 2018$27,000
-20.6%
10,0000.0%0.00%
Q3 2018$34,000
+30.8%
10,0000.0%0.00%
Q2 2018$26,000
+18.2%
10,0000.0%0.00%
Q1 2018$22,000
+10.0%
10,0000.0%0.00%
Q4 2017$20,00010,000
+49900.0%
0.00%
Q1 2016$0
-100.0%
20
-98.0%
0.00%
Q1 2015$3,0000.0%1,0000.0%0.00%
Q4 2014$3,0001,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 4,598,329$10,852,0004.99%
Soleus Capital Management, L.P. 864,100$2,039,0002.37%
Healthcare Value Capital, LLC 500,000$1,180,0001.98%
ORACLE INVESTMENT MANAGEMENT INC 1,227,114$2,896,0000.86%
PERKINS CAPITAL MANAGEMENT INC 232,166$548,0000.66%
Stonepine Capital Management, LLC 151,189$357,0000.38%
Zebra Capital Management LLC 84,963$200,0000.32%
Intrinsic Edge Capital Management LLC 1,000,000$2,360,0000.31%
Alambic Investment Management, L.P. 46,069$109,0000.26%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$473,0000.26%
View complete list of ANTARES PHARMA INC shareholders